Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Pluripotent Stem Cells in Translation: Preclinical Considerations (Day 1)

Loading video...

636 Views  
   
Air date: Tuesday, July 10, 2012, 8:30:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 636, (224 Live, 412 On-demand)
Category: Conferences
Runtime: 05:42:50
Description: The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. The object of the series is to have an informative interchange between funders (NIH and non-profit organizations), regulators (FDA), industry, and academic researchers on how to develop and provide to the public medical advances using pluripotent stem cells. This is the second workshop of the series.

This two-day workshop, “Pluripotent Cells in Translation: Preclincal Considerations,” is scheduled for July 10-11, 2012, at Natcher Auditorium on the NIH campus in Bethesda, Maryland. This meeting is unique in that its focus is on how to navigate BOTH regulatory and research pathways and is primarily aimed at investigators interested in translational research utilizing pluripotent stem cells. The first workshop, “Pluripotent Cells in Translation: Early Decisions,” was held in March 2011. The third workshop will focus on clinical trials and will be held in 2013.

For more information go to http://www.cvent.com/events/pluripotent-stem-cells-in-translation-preclinical-considerations/event-summary-732229f0fec44e3fa2cc156f56b846b4.aspx
Debug: Show Debug
NLM Title: Pluripotent stem cells in translation : preclinical considerations [electronic resource] / NIH and FDA.
Author: National Institutes of Health (U.S.).
Publisher:
Abstract: (CIT): The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. The object of the series is to have an informative interchange between funders (NIH and non-profit organizations), regulators (FDA), industry, and academic researchers on how to develop and provide to the public medical advances using pluripotent stem cells. This is the second workshop of the series. This two-day workshop, "Pluripotent Cells in Translation: Preclincal Considerations," is scheduled for July 10-11, 2012, at Natcher Auditorium on the NIH campus in Bethesda, Maryland. This meeting is unique in that its focus is on how to navigate BOTH regulatory and research pathways and is primarily aimed at investigators interested in translational research utilizing pluripotent stem cells. The first workshop, "Pluripotent Cells in Translation: Early Decisions," was held in March 2011. The third workshop will focus on clinical trials and will be held in 2013.
Subjects: Drug Evaluation, Preclinical
Pluripotent Stem Cells
Publication Types: Congresses
Webcasts
Download: To download this event, select one of the available bitrates:
[256k]  [512k]    How to download a Videocast
Caption Text: Download Caption File
NLM Classification: QU 325
NLM ID: 101589406
CIT Live ID: 11344
Permanent link: http://videocast.nih.gov/launch.asp?17347